PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?

PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?

Background: prostate-specific membrane antigen (PSMA) ligand PET has been recently incorporated into international guidelines for several different indications in prostate cancer (PCa) patients. However, there are still some open questions regarding the role of PSMA ligand PET in castration-resistan...

Full description

Bibliographic Details
Main Authors: Luca Urso, Luca Filippi, Angelo Castello, Maria Cristina Marzola, Mirco Bartolomei, Corrado Cittanti, Luigia Florimonte, Massimo Castellani, Paolo Zucali, Alessio Bruni, Roberto Sabbatini, Massimo Dominici, Stefano Panareo, Laura Evangelista
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Journal of Clinical Medicine
Subjects:
prostate cancer
PCa
castration-resistant prostate cancer
PSMA PET
FDG PET
pitfalls
Online Access:https://www.mdpi.com/2077-0383/12/22/7130

Internet

https://www.mdpi.com/2077-0383/12/22/7130

Similar Items